Ocuphire Pharma
drug development history and patents | Ocuphire Pharma
Company
Deck Type
Deck date
November 2023
Slide
17 of 42
Related slides by other companies
Avenue Therapeutics
IPO
October 2022
safety and efficacy has been demonstrated in two phase trials in over patients | Avenue Therapeutics
NeuroSense Therapeutics
Investor Presentation
June 2023
phase trial design | NeuroSense Therapeutics
ATAI
Investor Presentation
March 2023
phase proof of concept trial design all subjects tid tid placebo trial status in data anticipated randomized week study of and patients with | ATAI
Chimerix
Investor Presentation
May 2023
aligned criteria for phase efficacy analysis to isolate single agent activity eligibility | Chimerix
Other recent decks by Ocuphire Pharma
See all presentations (10 decks)
Investor Presentation
August 2023
Investor Presentation
May 2023
Results
January 2023
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io